These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15696693)

  • 21. Massive blood transfusion in a tertiary referral hospital. Clinical outcomes and haemostatic complications.
    Harvey MP; Greenfield TP; Sugrue ME; Rosenfeld D
    Med J Aust; 1995 Oct; 163(7):356-9. PubMed ID: 7565259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet function testing to assess effectiveness of platelet transfusion therapy.
    Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
    Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.
    Abdel-Wahab OI; Healy B; Dzik WH
    Transfusion; 2006 Aug; 46(8):1279-85. PubMed ID: 16934060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is transfusion of fresh plasma after cardiac operations indicated?
    Martinowitz U; Goor DA; Ramot B; Mohr R
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):92-8. PubMed ID: 2366571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood products usage in cardiac surgery.
    Dellora C; Minola P; Parodi F; De Gasperis C
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():159-61. PubMed ID: 7886561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood component therapy in open heart surgery.
    Daszyński J; Ciszewski T
    Mater Med Pol; 1989; 21(3):207-11. PubMed ID: 2491272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of the clinical laboratory for patients with massive transfusion undergoing elective surgery].
    Kino S; Takenaka S; Niizeki N; Hanada D; Tomoda Y; Akasaka K; Ito Y
    Rinsho Byori; 2011 Jul; 59(7):670-5. PubMed ID: 21874793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets--a review of the current literature.
    Johansson PI; Stensballe J
    Transfusion; 2010 Mar; 50(3):701-10. PubMed ID: 19929864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of massive operative blood loss.
    Kozek-Langenecker S
    Minerva Anestesiol; 2007; 73(7-8):401-15. PubMed ID: 17380100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advancement in the preparation of red cell concentrates and platelet concentrates].
    Inaba S
    Masui; 2011 Jan; 60(1):23-30. PubMed ID: 21348247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood component therapy: differential indication for erythrocyte transfusion].
    Bergmann H
    Infusionsther Klin Ernahr; 1980 Aug; 7(4):184-9. PubMed ID: 7191413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New aspects of therapy with blood and blood components].
    Frick U; Frick G
    Zentralbl Chir; 1983; 108(23):1478-84. PubMed ID: 6666422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of intraoperative using cell saver on blood sparing and its impact on coagulation function].
    Guo XY; Duan H; Wang JJ; Luo AL; Ye TH; Huang YG; Ren HZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):188-91. PubMed ID: 15171559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
    Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The blood bank: from provider to partner in treatment of massively bleeding patients.
    Johansson PI
    Transfusion; 2007 Aug; 47(2 Suppl):176S-181S; discussion 182S-183S. PubMed ID: 17651347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHEMOTHERAPY ANALYSIS IN MASSIVE TRANSFUSION SYNDROME.
    Stanković B; Stojanović G
    Med Pregl; 2016; 69(1-2):37-43. PubMed ID: 27498532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Factors affecting blood loss in total knee arthroplasty patients].
    Durasek J; Dovzak-Bajs I; Sarić V
    Acta Med Croatica; 2010 Jul; 64(3):209-14. PubMed ID: 20922865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The blood bank physician as a hemostasis consultant.
    Sweeney JD
    Transfus Apher Sci; 2008 Oct; 39(2):145-50. PubMed ID: 18760674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence and triggers for the transfusion of blood and blood products.
    Shah A; Stanworth SJ; McKechnie S
    Anaesthesia; 2015 Jan; 70 Suppl 1():10-9, e3-5. PubMed ID: 25440390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.